Evidence for epigenetic mechanisms that silence both basal and immune-stimulated transcription of the IL-8 gene.
It is becoming increasingly clear that epigenetic silencing of gene transcription plays a critical role in the regulation of gene expression in many biological processes. Tight regulation of immunomodulatory substances that are important for the initiation of the inflammatory cascade, such as chemoattractive cytokines, is essential to prevent initiation of unrestrained immune activation. Using the Caco-2 intestinal cell line as a model, we reveal two distinctly different mechanisms by which the gene for the neutrophil chemoattractive cytokine IL-8 is silenced. Nuclear run-on studies, as well as stably transfected reporter and marked minigene constructs, demonstrate that cellular differentiation inhibits immune-activated transcription of the IL-8 gene, a mechanism that is dependent on histone deacetylase activity. Unexpectedly, this silencing mechanism does not involve previously described regulatory elements in the IL-8 promoter but rather cis-acting regions located at a distance from the IL-8 gene locus. Genomic elements distant to the immediate IL-8 locus are also required to silence aberrant basal transcriptional activity of the IL-8 promoter in the absence of immune activation. However, in this case, silencing occurs in a histone deacetylase-independent fashion. These findings were confirmed in transgenic mice in which, in the absence of these elements, aberrant IL-8 gene activity was present primarily in the intestinal tract. Epigenetic silencing of cytokine gene transcription through distant genomic elements is an important level of gene regulation that may be relevant to the pathogenesis of immunologic disease states.
Wen
X
X
Division of Gastroenterology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Wu
G D
GD
D000818:Animals; D001482:Base Composition / Q000235:genetics / Q000276:immunology; D018938:Caco-2 Cells / Q000276:immunology* / Q000378:metabolism* / Q000473:pathology; D002454:Cell Differentiation / Q000235:genetics / Q000276:immunology; D002999:Clone Cells; D004273:DNA, Neoplasm / Q000235:genetics / Q000378:metabolism; D005260:Female; D017781:Genes, Immediate-Early / Q000276:immunology; D005819:Genetic Markers; D006655:Histone Deacetylases / Q000502:physiology; D006801:Humans; D007375:Interleukin-1 / Q000502:physiology; D016209:Interleukin-8 / Q000037:antagonists & inhibitors* / Q000096:biosynthesis / Q000235:genetics* / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D011401:Promoter Regions, Genetic / Q000276:immunology; D014158:Transcription, Genetic / Q000276:immunology*; D015533:Transcriptional Activation / Q000235:genetics / Q000276:immunology; D014162:Transfection; D019076:Transgenes / Q000276:immunology
D004273:DNA, Neoplasm; D005819:Genetic Markers; D007375:Interleukin-1; D016209:Interleukin-8; D006655:Histone Deacetylases